US Physical Therapy Inc USPH
$78.48
-3.40%
at last close
Analyst Consensus
- Consensus Rating
- Buy (4 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $99.50
- Implied Upside
- +26.8%
- Price Target Range
- $98.00 – $102.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-10 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $90 → $98 |
| 2026-06-24 | CitizensConstantine Davides |
Reiterates | Market outperform | $98 |
| 2026-05-13 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $103 → $90 |
| 2026-05-08 | CitizensConstantine Davides |
Maintains | Market outperform | $113 → $98 |
| 2026-03-10 | JefferiesBrian Tanquilut |
Assumes | Buy | $102 |
| 2026-02-20 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $103 |
| 2026-01-05 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $103 |
| 2025-11-24 | JP MorganBenjamin Rossi |
Maintains | Overweight | $110 → $100 |
| 2025-10-24 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $103 |
| 2025-09-18 | JP MorganBenjamin Rossi |
Assumes | Overweight | $110 |
| 2025-08-08 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $98 → $103 |
| 2025-07-01 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $98 |
| 2025-04-22 | JMP SecuritiesConstantine Davides |
Reiterates | Market outperform | $113 |
| 2025-03-19 | JP MorganCalvin Sternick |
Maintains | Overweight | $120 → $110 |
| 2025-02-28 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $108 → $98 |
| 2024-12-16 | B of A SecuritiesJoanna Gajuk |
Upgrades | Neutral → Buy | $100 → $115 |
| 2024-12-16 | JMP SecuritiesConstantine Davides |
Initiates coverage on | Market outperform | $113 |
| 2024-12-03 | JP MorganCalvin Sternick |
Maintains | Overweight | $117 → $120 |
| 2024-11-21 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $108 |
| 2024-11-07 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $108 |
| 2024-10-09 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $108 |
| 2024-10-07 | B of A SecuritiesJoanna Gajuk |
Downgrades | Buy → Neutral | $114 → $90 |
| 2024-09-20 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $108 |
| 2024-08-15 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $122 → $108 |
| 2024-05-09 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $122 |
| 2024-03-13 | JP MorganCalvin Sternick |
Maintains | Overweight | $99 → $117 |
| 2024-03-01 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $120 → $122 |
| 2024-01-03 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $111 → $120 |
| 2023-11-17 | JP MorganCalvin Sternick |
Maintains | Overweight | $108 → $99 |
| 2023-11-09 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $124 → $111 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $78.48
- Market Cap
- $1.21 billion
- 52-Week Range
- $58.19 – $93.50
- Average Volume
- 242K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.